EU IVDR 2017/746: Overview of Regulation Changes

The In Vitro medical devices faced the implementation of the European Community Directive 98/79/EC in 1998. The In Vitro Diagnostic Directive (IVDD) 98/79/EC has been now transformed to In Vitro Diagnostic Regulation (IVDR) 2017/746/EU. The official timeline for this transition phase to complete implementation is 5 years (26th May 2022). The current regulatory framework for…

INNOVATIONS IN PEER-REVIEW

Peer Review is the process of evaluation of manuscripts submitted for scientific publication in journals/books, pre-clinical or clinical study reports, research progress reports etc., by experts or peers with similar competence as manuscript authors. It plays a pivotal role in scholarly publications with objective to ascertain quality, reliability and credibility of the work reported in…

Moving to Virtual Clinical Trials

In the clinical trials industry, 80% of trials do not meet enrolment timelines, leading to a loss of $8 million per day. Delayed enrolment not only impacts trial timelines, but more trials are being cancelled because of it, preventing investigators from determining the safety and efficacy of what could be promising new therapies for patients…

Financial Disclosures in Medical Publishing

Introduction Financial disclosures enable the readers to evaluate the potential conflict of interest (COI) which probably builds the trust of transparency in the medical publishing’s. Importance The financial disclosures are made available to the readers either in the published article or by posting the submitted financial disclosure forms online along with the published article. It…

Myths about HIV/AIDS: Busted

Ever since HIV/AIDS is discovered, there have been lots of rumors surrounding it. This article aims at busting those myths and presenting the fact. HIV-Human Immunodeficiency Virus attacks the immune system of human body and makes a person weaker and increases his disability to fight against diseases. This is caused by having unprotected sex with…